ranitidine has been researched along with Lung Neoplasms in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 6 (50.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, Y; Fu, H; Li, S; Obianyo, O; Qi, Q; Ye, K | 1 |
Bradbury, PA; Hilton, JF; Seymour, L; Shepherd, FA; Tu, D | 1 |
Oxberry, SG; Veevers, AE | 1 |
Inoue, K; Kai, T; Koh, J; Mihara, H; Mochizuki, H; Okubo, K; Saito, T; Sato, K; Tabei, T | 1 |
den Bakker, MA; Gelderblom, H; Kloover, JS; van Meerbeeck, JP | 1 |
Khoo, NK; Lala, PK; Saarloos, MN | 1 |
Doornbos, JF; Friedland, J; Launspach, J; Mitros, F; Soffer, EE; Summers, RW | 1 |
Asea, A; Hellstrand, K; Hermodsson, S | 2 |
Diergarten, K; Goes-Schmieder, R; Kober, B; Kolotas, C; Martin, T; Mitrou, PS; Schneider, LV; Vogt, HG; Zamboglou, N | 1 |
Giannikos, L; Gogas, J; Kosmas, C; Polyzos, A; Tsavaris, N | 1 |
Li, GH; Liu, F; Sun, B | 1 |
4 trial(s) available for ranitidine and Lung Neoplasms
Article | Year |
---|---|
Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
Topics: Adult; Aged; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Neutropenia; Paclitaxel; Ranitidine; Soft Tissue Neoplasms; Vomiting, Anticipatory | 2003 |
Morphology and pathology of radiation-induced esophagitis. Double-blind study of naproxen vs placebo for prevention of radiation injury.
Topics: Double-Blind Method; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naproxen; Prospective Studies; Radiation Injuries; Ranitidine | 1994 |
Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
Topics: Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Clemastine; Combined Modality Therapy; Dexamethasone; Drug Administration Schedule; Drug Hypersensitivity; Drug Tolerance; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Radiotherapy Dosage; Ranitidine; Remission Induction; Treatment Outcome | 1996 |
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
Topics: Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Nervous System; Dexamethasone; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Premedication; Promethazine; Ranitidine; Safety | 1997 |
8 other study(ies) available for ranitidine and Lung Neoplasms
Article | Year |
---|---|
Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Female; Humans; Lung; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Structure-Activity Relationship; Xanthine | 2017 |
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Ranitidine; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2013 |
Ranitidine: forgotten drug of delayed gastric emptying.
Topics: Adenocarcinoma; Aged; Female; Gastrointestinal Agents; Gastroparesis; Humans; Injections, Subcutaneous; Lung Neoplasms; Octreotide; Palliative Care; Pancreatic Neoplasms; Ranitidine | 2017 |
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clemastine; Dexamethasone; Drug Hypersensitivity; Fatal Outcome; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Ranitidine; Risk Factors | 2004 |
Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Immunotherapy, Adoptive; Indomethacin; Interleukin-2; Killer Cells, Natural; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Neoplasm Transplantation; Ranitidine | 1993 |
Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice.
Topics: Animals; Antibodies; Cytotoxicity, Immunologic; Female; G(M1) Ganglioside; Histamine; Histamine H2 Antagonists; Immunity, Cellular; Interferon-alpha; Interleukin-2; Killer Cells, Natural; Lung Neoplasms; Lymphoma; Melanoma, Experimental; Mice; Ranitidine; Receptors, Histamine H2 | 1996 |
Role of histamine in natural killer cell-mediated resistance against tumor cells.
Topics: Animals; Cytotoxicity, Immunologic; Dimaprit; Histamine; Immunity, Cellular; Interleukin-2; Killer Cells, Natural; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasms, Experimental; Ranitidine; Receptors, Histamine H2; Thiourea | 1990 |
[Immunomodulation of cimetidine in mice].
Topics: Animals; Cimetidine; Female; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Ranitidine; Rosette Formation | 1988 |